Gregory Sargen - Net Worth and Insider Trading

Gregory Sargen Net Worth

The estimated net worth of Gregory Sargen is at least $0 dollars as of 2024-04-25. Gregory Sargen is the Director of Avid Bioservices Inc and owns about 0 shares of Avid Bioservices Inc (CDMO) stock worth over $0. Gregory Sargen is also the CFO & EVP, Corp. Dev. of Cambrex Corp and owns about 0 shares of Cambrex Corp (CBM) stock worth over $0. Details can be seen in Gregory Sargen's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Gregory Sargen has not made any transactions after 2023-04-11 and currently still holds the listed stock(s).

Transaction Summary of Gregory Sargen

To

Gregory Sargen Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Gregory Sargen owns 2 companies in total, including Protara Therapeutics Inc (TARA) , and Avid Bioservices Inc (CDMO) .

Click here to see the complete history of Gregory Sargen’s form 4 insider trades.

Insider Ownership Summary of Gregory Sargen

Ticker Comapny Transaction Date Type of Owner
TARA Protara Therapeutics Inc 2020-01-09 director
CDMO Avid Bioservices Inc 2023-04-11 director

Gregory Sargen Latest Holdings Summary

Gregory Sargen currently owns a total of 2 stocks. Among these stocks, Gregory Sargen owns 0 shares of Avid Bioservices Inc (CDMO) as of April 11, 2023, with a value of $0 . Gregory Sargen also owns 0 shares of Cambrex Corp (CBM) as of December 4, 2019, with a value of $0 .

Latest Holdings of Gregory Sargen

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CDMO Avid Bioservices Inc 2023-04-11 0 6.83 0
CBM Cambrex Corp 2019-12-04 0 59.99 0

Holding Weightings of Gregory Sargen


Gregory Sargen Form 4 Trading Tracker

According to the SEC Form 4 filings, Gregory Sargen has made a total of 1 transactions in Avid Bioservices Inc (CDMO) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Avid Bioservices Inc is the sale of 7,011 shares on April 11, 2023, which brought Gregory Sargen around $141,903.

According to the SEC Form 4 filings, Gregory Sargen has made a total of 1 transactions in Cambrex Corp (CBM) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Cambrex Corp is the sale of 165,925 shares on December 4, 2019, which brought Gregory Sargen around $10 Million.

Insider Trading History of Gregory Sargen

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Gregory Sargen Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Gregory Sargen Ownership Network

Ownership Network List of Gregory Sargen

No Data

Ownership Network Relation of Gregory Sargen


Gregory Sargen Owned Company Details

What does Protara Therapeutics Inc do?

Who are the key executives at Protara Therapeutics Inc?

Gregory Sargen is the director of Protara Therapeutics Inc. Other key executives at Protara Therapeutics Inc include Chief Financial Officer Patrick Fabbio , 10 percent owner Opaleye Management Inc. , and director & CEO and President Jesse Shefferman .

Protara Therapeutics Inc (TARA) Insider Trades Summary

Over the past 18 months, Gregory Sargen made no insider transaction in Protara Therapeutics Inc (TARA). Other recent insider transactions involving Protara Therapeutics Inc (TARA) include a net sale of 15,473 shares made by Opaleye Management Inc. ,

In summary, during the past 3 months, insiders sold 0 shares of Protara Therapeutics Inc (TARA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 15,473 shares of Protara Therapeutics Inc (TARA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 15,473 shares.

Protara Therapeutics Inc (TARA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Protara Therapeutics Inc Insider Transactions

No Available Data

Gregory Sargen Mailing Address

Above is the net worth, insider trading, and ownership report for Gregory Sargen. Currently GuruFocus does not have mailing address information for Gregory Sargen.

Discussions on Gregory Sargen

No discussions yet.